Search

Your search keyword '"TRANQUILIZING drugs"' showing total 5,866 results

Search Constraints

Start Over You searched for: Descriptor "TRANQUILIZING drugs" Remove constraint Descriptor: "TRANQUILIZING drugs" Database Academic Search Index Remove constraint Database: Academic Search Index
5,866 results on '"TRANQUILIZING drugs"'

Search Results

1. The impact of delirium on clinical and functional outcomes in hospitalized patients with acute coronary syndrome.

2. Trends in the nonmedical misuse of benzodiazepines and Z‐hypnotics among school‐aged adolescents (2016–2021): gender differences and related factors.

3. Overall congenital defect risk unchanged by antidepressant/benzo use.

4. Comparison of the anesthetic effects of remimazolam tosilate and remimazolam besylate in daytime hysteroscopic surgery.

5. Software‐assisted automated detection and identification of "unknown" analogues of benzodiazepines in liquid chromatography mass spectrometry analysis.

6. Comparison of hypotension between propofol and remimazolam-propofol combinations sedation for day-surgery hysteroscopy: a prospective, randomized, controlled trial.

7. Fall Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System.

8. Long‐term psycho‐traumatic consequences of the COVID‐19 health crisis among emergency department healthcare workers.

9. When Should Pharmacological Interventions for Insomnia Be Recommended?

10. Effect of remimazolam for general anesthesia on postoperative nausea and vomiting: A systematic review and meta-analysis.

11. Research Letter: Dispensing of psychotropic medications in Australia between 2013 and 2022.

12. PICU Admission of Children for Status Epilepticus: Is There a Different Approach Between Referral and Second-Level Hospitals in an Italian Region?

13. Effect of Phenobarbital-Based Alcohol Withdrawal Protocol on Provider Practice and Patient Outcomes—A Quality Improvement Study.

14. Trends in Drug Overdose Deaths by Intent and Drug Categories, United States, 1999‒2022.

15. Clustering of restorative sleep and lifestyle habits in Japanese male working population.

16. Outpatient Prescriptions for Insomnia Medications During the First Year Following Combat-Related Amputations.

17. Heautoscopic hallucinations in first episode psychosis: report of one case and clinical overview.

18. Network Pharmacology and Molecular Docking Analysis of Morinda citrifolia Fruit Metabolites Suggest Anxiety Modulation through Glutamatergic Pathways.

19. Quality of life, pain and use of analgesic, anxiolytic and antidepressant medication, in people living in care homes.

20. A pilot study on in-utero exposure to psychotropic drugs: A comparison of pharmacological classes on neonatal and maternal outcomes.

21. Comprehensive signal detection of delirium-associated medication using the Food and Drug Administration Adverse Event Reporting System.

22. N-3 PUFA supplementation alleviates anxiety symptoms by manipulating erythrocyte fatty acid levels in depression.

23. Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020.

24. Nursing interventions for people who use new psychoactive substances.

25. Effects of policy interventions on psychotropic polypharmacy in Japanese older adults.

26. Remimazolam – Update zu Grundlagen und klinischem Potenzial.

27. Analysis of jail populations reveals jump in mental health prescribing.

28. Modeling Changes of Fatal Xylazine-Involved Drug Overdoses in Connecticut Across Time.

29. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use.

30. Pain Management Strategies before Pan‐Retinal Photocoagulation for Diabetic Retinopathy: A Systematic Review.

31. The influence of sex on the dosage of remimazolam co-administered with remifentanil for loss of consciousness in adult patients: an up-and-down sequential allocation trial.

32. Expectations and needs of people with illicit substance use disorders in general practice: a qualitative study in Belgium.

33. Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience.

34. Kennedy's disease.

35. The surge of bromazolam‐related fatalities replacing other novel designer benzodiazepines‐related fatalities in San Francisco.

36. The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco.

37. Phenobarbital as a Sedation Strategy to Reduce Opioid and Benzodiazepine Burden in Neonatal Extracorporeal Membrane Oxygenation.

38. Exploring the sedative properties of natural molecules from hop cones (Humulus lupulus) as promising natural anxiolytics through GABA receptors and the human serotonin transporter.

39. The effects of remimazolam combined with sufentanil on respiration, circulation and sedation level in patients undergoing colonoscopy.

40. Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK/ERK pathway.

41. Last general practitioner consultation during the final month of life: a national medical record review of suicides in Sweden.

42. Incompatibility of the short-acting benzodiazepine remimazolam with common perioperative medication.

43. Comparison of remimazolam tosilate and propofol during induction and maintenance of general anesthesia in patients undergoing laparoscopic cholecystectomy: a prospective, single center, randomized controlled trial.

44. Comparing the Sedative Effects of Intranasal Dexmedetomidine, Midazolam, and Ketamine in Outpatient Pediatric Surgeries: A Randomized Clinical Trial.

45. Factors associated with potentially inappropriate medications in elderly with multiple myeloma.

46. Failure to reduce benzodiazepine prescriptions through the implementation of a psychological intervention for insomnia in an Italian mental health service.

47. Spousal bereavement and four‐year trajectories of medication use: A nationwide register‐based study in Swedish older adults.

48. Dream of the Endless: Updates in Agents for Procedural Sedation.

49. Long-term use of prescription opioids for non-cancer pain and mortality: a population-based, propensity-weighted cohort study.

50. Trajectories and predictive factors of weight recovery in patients with anorexia nervosa completing treatment. A latent class mixed model approach.

Catalog

Books, media, physical & digital resources